Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer: initial clinical experience

2011 ◽  
Vol 25 (10) ◽  
pp. 3322-3329 ◽  
Author(s):  
Jun Seok Park ◽  
Gyu-Seog Choi ◽  
Kyoung Hoon Lim ◽  
You Seok Jang ◽  
Hye Jin Kim ◽  
...  
2015 ◽  
Vol 111 (4) ◽  
pp. 459-464 ◽  
Author(s):  
Min Ju Kim ◽  
Tae Hyun Kim ◽  
Dae Yong Kim ◽  
Sun Young Kim ◽  
Ji Yeon Baek ◽  
...  

2007 ◽  
Vol 16 (1) ◽  
pp. 177-197 ◽  
Author(s):  
Melinda M. Mortenson ◽  
Vijay P. Khatri ◽  
Joseph J. Bennett ◽  
Nicholas J. Petrelli

2015 ◽  
Vol 100 (3) ◽  
pp. 417-422 ◽  
Author(s):  
Masayoshi Tokuoka ◽  
Yoshihito Ide ◽  
Mitsunobu Takeda ◽  
Yasuji Hashimoto ◽  
Jin Matsuyama ◽  
...  

We prove the safety and feasibility of single-incision plus 1 port (SILS+1) laparoscopic total mesorectal excision (TME) + lateral pelvic lymph node dissection (LPLD) via a medial umbilical approach for rectal cancer. Only a few reports have been published about single-incision multiport laparoscopic low anterior resection with LPLD. Recently, minimally invasive surgery such as single-incision plus 1 port (SILS + 1) for advanced rectal cancer has been reported as safe and feasible. To our knowledge, this is the first reported case of SILS + 1 used for LPLD. A wound protector was inserted through a 30-mm transumbilical incision. Next, a single-port access device was mounted to the wound protector and 3 ports (5 mm each) were placed. A 12-mm port was inserted in the right lower quadrant. Super-low anterior resection of the rectum and bilateral LPLD and temporary ileostomy were performed with SILS + 1, with a blood loss of 50 mL and a total surgical time of 525 minutes. The time for right lateral dissection was 74 minutes; the time for left lateral dissection was 118 minutes. The total number of dissected lymph nodes was 57 and the number of lateral lymph nodes dissected was 21 (8 left pelvic lymph nodes, 13 right pelvic lymph nodes). No postoperative anastomotic insufficiency or voiding dysfunction was observed. We have documented the safety and feasibility of SILS + 1-TME + LPLD via a medial umbilical approach for rectal cancer.


Sign in / Sign up

Export Citation Format

Share Document